SEP 12, 2019 10:30 AM PDT

Analysis of human gut microbiomes and antibiotic resistomes of pediatric patients undergoing stem cell transplantation

Sponsored by: QIAGEN
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Director of Global Product Management, Genome Analysis, QIAGEN
    Biography
      Jonathan Jacobs Ph.D. has over 18 years of experience in bioinformatics, molecular genetics, and microbial genomics. In 1999, he received his BSc. in Plant Biology from the University of Arizona's College of Agriculture, and in 2006 he earned his PhD in Molecular Genetics from the University of Maryland, College Park. Dr. Jacobs was then awarded a Postdoctoral Research Fellowship at the National Cancer Institute, where his research focused on epigenetic control of gene expression. Following his postdoc, he obtained several patents in cell line engineering while a scientist in MedImmune's Antibody Discovery & Protein Engineering group. He later went on to join MRIGlobal to lead applied genomics programs. For eight years, Dr. Jacobs led MRIGlobal's pathogen genomics and bioinformatics team, developing systems for mobile pathogen diagnostics, microbial forensics, and point-of-need field testing. He was also the genomics team lead for U.S. Defense Threat Reduction Agency's S2S/PanGIA program: a deployable metagenomics system for use in clinical diagnostic and environmental surveillance laboratories. Dr. Jacobs joined QIAGEN in 2018 as Director of Global Product Management, Genome Analysis, where he is leading the development road-map for CLC bio, a portfolio of enterprise level bioinformatics software solutions.

    Abstract

    The emergence and spread of antimicrobial-resistant (AMR) bacteria and resistance mechanisms pose a serious challenge to laboratories in both hospital clinical microbiology and public health settings. Accordingly, elevated vigilance by antibiotic stewardship programs at a local level is required to limit the spread and dissemination of drug-resistant pathogens among clinical patient populations. Whole genome sequencing, as opposed to traditional culturing and isolate typing, is proving to be an effective means to rapidly assess patient samples for the presence of potentially drug-resistant pathogens. The cost of whole genome sequencing continues to decline; however, there is an increasing need for effective bioinformatic analysis pipelines suitable for routine use by clinical microbiology laboratories.


    In this presentation, we use QIAGEN’s CLC Microbial Genomics Module, an extension to the CLC Genomics Workbench software platform, and the new QIAGEN Microbial Insights AR Database (QMI-AR), to analyze public gut microbiome data obtained from pediatric stem cell transplantation patients. We demonstrate how CLC Genomics Workbench platform, along with the QMI-AR database, can be used to profile microbiome samples for their constituent bacteria, and identify genomic markers for antimicrobial resistance. Furthermore, we demonstrate how the CLC platform can be used to build customized analysis workflows designed to automate the analysis and reporting of results, an essential component of any laboratory where standard operating procedures and rigorous results reporting are expected and required.


    Learning Objectives:

    1. Detect antimicrobial resistance genes using multiple methods and databases, including the new QIAGEN Microbial Insights AR database.
    2. Determine the taxonomic profile of shotgun metagenomic samples
    3. Build reproducible workflows for routine analysis
    4. Use tools from CLC Microbial Genomics Module to identify potential mobile AMR markers found in plasmids
    5. Visualize these markers in a reference genome using the new Genome Browser


    Show Resources
    You May Also Like
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    Loading Comments...
    Show Resources
    Attendees
    • See more